Heparan sulfate proteoglycans and heparanases in Alzheimer's disease: current outlook and potential therapeutic targets
Open Access
- 1 January 2017
- journal article
- perspective
- Published by Medknow in Neural Regeneration Research
- Vol. 12 (6) , 914-915
Abstract
Neural Regen Res, Official publication of Publishing House of Neural Regeneration Research China Association of Rehabilitation Medicine,ChinaKeywords
This publication has 12 references indexed in Scilit:
- Alzheimer DiseaseContinuum, 2016
- The amyloid hypothesis of Alzheimer's disease at 25 yearsEMBO Molecular Medicine, 2016
- Heparanase and heparanase 2 display differently deregulation in neuroendocrine tumors, depending on their differentiation grade2015
- Overexpression of Heparanase Lowers the Amyloid Burden in Amyloid-β Precursor Protein Transgenic MiceJournal of Biological Chemistry, 2015
- An unusual cause of jaundice in a patient with breast cancerBMJ Case Reports, 2014
- Prion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic TargetJournal of Biological Chemistry, 2014
- Towards Understanding the Roles of Heparan Sulfate Proteoglycans in Alzheimer’s DiseaseBioMed Research International, 2014
- Proteoglycans in the central nervous system: Role in development, neural repair, and Alzheimer's diseaseIUBMB Life, 2013
- Heparanase 2 Interacts with Heparan Sulfate with High Affinity and Inhibits Heparanase ActivityJournal of Biological Chemistry, 2010
- Accumulation of heparan sulfate proteoglycans in cerebellar senile plaquesNeurobiology of Aging, 2002